ZA200707979B - Oral dosage forms of Gemcitabine derivatives - Google Patents

Oral dosage forms of Gemcitabine derivatives

Info

Publication number
ZA200707979B
ZA200707979B ZA200707979A ZA200707979A ZA200707979B ZA 200707979 B ZA200707979 B ZA 200707979B ZA 200707979 A ZA200707979 A ZA 200707979A ZA 200707979 A ZA200707979 A ZA 200707979A ZA 200707979 B ZA200707979 B ZA 200707979B
Authority
ZA
South Africa
Prior art keywords
dosage forms
oral dosage
gemcitabine derivatives
gemcitabine
derivatives
Prior art date
Application number
ZA200707979A
Other languages
English (en)
Inventor
Myhren Finn
Eriksen Ole Henrik
Sandvold Marit Liland
Original Assignee
Clavis Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clavis Pharma As filed Critical Clavis Pharma As
Publication of ZA200707979B publication Critical patent/ZA200707979B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA200707979A 2005-03-18 2007-09-17 Oral dosage forms of Gemcitabine derivatives ZA200707979B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20051467A NO322682B1 (no) 2005-03-18 2005-03-18 Anvendelse av gemcitabinderivater for fremstilling av orale doseringsformer ved kreftbehandling, samt slike orale doseringsformer

Publications (1)

Publication Number Publication Date
ZA200707979B true ZA200707979B (en) 2008-11-26

Family

ID=35267108

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200707979A ZA200707979B (en) 2005-03-18 2007-09-17 Oral dosage forms of Gemcitabine derivatives

Country Status (13)

Country Link
US (1) US20080280851A1 (fr)
EP (1) EP1858527A4 (fr)
JP (1) JP2008533135A (fr)
KR (1) KR20070120539A (fr)
AU (1) AU2006223757A1 (fr)
CA (1) CA2600399A1 (fr)
IL (1) IL185866A0 (fr)
NO (1) NO322682B1 (fr)
NZ (1) NZ561377A (fr)
RU (1) RU2007138582A (fr)
UA (1) UA90893C2 (fr)
WO (1) WO2006098628A1 (fr)
ZA (1) ZA200707979B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497292B2 (en) * 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
WO2010039039A1 (fr) * 2008-10-03 2010-04-08 Clavis Pharma Asa Formulations orales de dérivés de gemcitabine
CN101525361B (zh) 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
WO2013009701A2 (fr) 2011-07-08 2013-01-17 The University Of North Carolina At Chapel Hill Nanoparticules de métal-bisphosphonate pour thérapie anticancéreuse et imagerie, ainsi que pour traiter des troubles des os
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
CA2891124A1 (fr) 2012-11-13 2014-05-22 BoYen Therapeutics, Inc. Promedicaments de la gemcitabine et utilisations
US10517822B2 (en) 2013-11-06 2019-12-31 The University Of Chicago Nanoscale carriers for the delivery or co-delivery of chemotherapeutics, nucleic acids and photosensitizers
WO2015116782A1 (fr) 2014-01-29 2015-08-06 Board Of Regents, The University Of Texas System Dérivés d'un analogue de nucléobase et leurs applications
EP3439666A4 (fr) 2016-05-20 2019-12-11 The University of Chicago Nanoparticules pour chimiothérapie, thérapie ciblée, thérapie photodynamique, immunothérapie et n'importe quelle combinaison de ces dernières
CN107184592A (zh) * 2017-05-17 2017-09-22 广东艾时代生物科技有限责任公司 吉西他滨在制备治疗类风湿性关节炎药物中的应用
EP3638367A4 (fr) 2017-08-02 2021-07-21 The University of Chicago Couches organométalliques nanométriques et nanoplaques organométalliques pour thérapie photodynamique induite par rayons x, radiothérapie, thérapie radiodynamique, chimiothérapie, immunothérapie, et toute combinaison de celles-ci
AU2019216531A1 (en) 2018-02-02 2020-09-24 Maverix Oncology, Inc. Small molecule drug conjugates of gemcitabine monophosphate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327358C (fr) * 1987-11-17 1994-03-01 Morio Fujiu Derives fluorocytidine
CA2278056C (fr) * 1997-01-24 2006-12-12 Norsk Hydro Asa Derives de gemcitabine
WO2004041203A2 (fr) * 2002-11-04 2004-05-21 Xenoport, Inc. Promedicaments de gemcitabine, leurs compositions pharmaceutiques et leurs utilisations

Also Published As

Publication number Publication date
EP1858527A4 (fr) 2010-10-27
JP2008533135A (ja) 2008-08-21
AU2006223757A1 (en) 2006-09-21
US20080280851A1 (en) 2008-11-13
WO2006098628A1 (fr) 2006-09-21
KR20070120539A (ko) 2007-12-24
UA90893C2 (ru) 2010-06-10
CA2600399A1 (fr) 2006-09-21
NO20051467D0 (no) 2005-03-18
IL185866A0 (en) 2008-01-06
RU2007138582A (ru) 2009-04-27
EP1858527A1 (fr) 2007-11-28
NZ561377A (en) 2009-10-30
NO322682B1 (no) 2006-11-27

Similar Documents

Publication Publication Date Title
IL185866A0 (en) Oral dosage forms of gemcitabine derivatives
IL268462A (en) Dosage form of risedronate
PT2077729E (pt) Formas orais probióticas
IL194277A0 (en) Solid oral dosage form containing an enhancer
EP2040731A4 (fr) Forme posologique solide à administrer par voie orale contenant un activateur
IL206159A0 (en) Oral pharmaceutical dosage forms
PT1802579E (pt) Derivados da 3-arilaminopiridina
PL1935395T3 (pl) Doustna kompozycja
IL187475A0 (en) Oral dosage form comprising an antimisuse system
IL196228A0 (en) 4-hydroxythiobenzamide derivatives of drugs
GB0710439D0 (en) Oral dosage form
IL184787A0 (en) Oral dosage form comprising rosiglitazone
EP1994042A4 (fr) Préparation de gemcitabine
IL184790A0 (en) Oral dosage form comprising rosiglitazone
GB0508174D0 (en) Oral hygiene compositions
IL192454A0 (en) Oral s-adenosylmethionine compositions
GB2424881B (en) Halophenyl derivatives of bisalkylfluorene
ZA200900230B (en) 4-hydroxythiobenzamide derivatives of drugs
IL186252A0 (en) Pharmaceutical compositions containing melatonin derivatives
IL198760A0 (en) Oral formulations
IL196320A0 (en) Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
GB0506832D0 (en) Oral insert
ZA200706292B (en) Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
DK1915137T3 (da) Oralt præparat med kontrolleret frisætning
ZA200810854B (en) Oral hygiene